UK markets closed

NanJing Pharmaceutical Company Limited (600713.SS)

Shanghai - Shanghai Delayed price. Currency in CNY
Add to watchlist
4.9100+0.0500 (+1.03%)
At close: 03:00PM CST
Show:
Balance sheet
Cash flow
Annual

Income statement

All numbers in thousands
Breakdown
ttm
31/12/2023
31/12/2022
31/12/2021
31/12/2020
Total revenue
53,460,419
53,589,665
50,221,564
45,123,195
39,817,364
Cost of revenue
50,120,208
50,276,362
46,962,430
42,185,985
37,286,150
Gross profit
3,340,211
3,313,303
3,259,134
2,937,210
2,531,214
Operating expenses
Research development
38,055
36,189
27,434
20,958
15,999
Selling general and administrative
1,292,767
1,308,402
1,287,501
1,175,280
1,007,644
Total operating expenses
1,785,992
1,794,931
1,759,860
1,605,857
1,412,919
Operating income or loss
1,554,219
1,518,372
1,499,273
1,331,353
1,118,294
Interest expense
367,511
370,864
325,508
58,810
48,184
Income before tax
995,240
978,068
906,012
838,866
677,799
Income tax expense
269,089
265,259
190,092
228,314
207,761
Income from continuing operations
726,151
712,809
715,920
610,552
470,038
Net income
587,751
577,826
595,668
505,183
376,413
Net income available to common shareholders
587,751
577,826
595,668
505,183
376,413
Basic EPS
0.43
-
0.47
0.48
0.36
Diluted EPS
0.43
-
0.47
0.48
0.36
Basic average shares
1,297,173
-
1,254,037
1,041,614
1,042,696
Diluted average shares
1,297,173
-
1,254,037
1,041,614
1,042,696